摘要
目的:探究二级预防概念下的预防管理对冠心病经皮冠状动脉治疗(PCI)术后患者心脏康复及抗血小板效果的影响。方法:选择2021年2月—2022年1月河南省胸科医院收治的160例冠心病PCI患者作为研究对象,采用随机数表法分为对照组和试验组,每组各80例。对照组患者采用常规护理,试验组患者在对照组的基础上采用联合二级预防概念下的预防管理,比较两组患者干预前、干预4个月后心脏康复和抗血小板效果情况。结果:干预4个月后,试验组患者左心室射血分数(LVEF)水平高于对照组患者,左心室舒张末期内径(LVEDD)水平、美国纽约心脏病学会(NYHA)分级均低于对照组患者,差异有统计学意义(t=8.583、8.695、6.455,P<0.05)。干预4个月后,试验组患者血小板最大聚焦率(MPAR)、血将P2Y12反应单位(PRU)水平均低于对照组患者,差异有统计学意义(t=8.573、8.661,P<0.05)。结论:基于二级预防理念对冠心病PCI术后患者进行预防管理,可有效提高患者抗血小板效果,改善其心脏康复水平。
Objective To explore the effect of preventive management under the concept of secondary prevention on cardiac rehabilitation and antiplatelet effect of coronary heart disease after PCI.Methods Selecting 160 samples in February 2021 and January 2022,dividing them into control group and experimental group with random sampling method.The concept of prevention and management was used in experimental group.The differences between cardiac rehabilitation and antiplatelet effect under the two intervention methods were compared.Results After 4 months of intervention,the LVEF level of the experimental group was significantly higher than that of the control group,and the LVEDD level and NYHA grade were significantly lower than those of the control group,with significant differences in each index between the two groups(t=8.583,8.695,6.455;P<0.05).After 4 months of intervention,the levels of MPAR and PRU in the experimental group were which were significantly lower than those in the control group(t=8.573,8.661;P<0.05).Conclusion Preventive management of patients with coronary heart disease after PCI based on the concept of secondary prevention can effectively improve the antiplatelet effect of patients and the level of cardiac rehabilitation.
作者
张娟
张玉英
王记培
Zhang Juan;Zhang Yuying;Wang Jipei(Department of Cardiovascular Medicine,Henan Chest Hospital,Zhengzhou,Henan,450008,China)
出处
《黑龙江医学》
2024年第8期935-937,共3页
Heilongjiang Medical Journal
关键词
二级预防
预防管理
冠心病
经皮冠状动脉治疗术
心脏康复
抗血小板
Secondary prevention
Preventive management
Coronary heart disease(CHD)
PCI surgery
Cardiac rehabilitation
Antiplatelet
